Congress Trades
Latest disclosures
| Chamber | Transaction Date | Member | Owner ▲ | Asset | Action | Amount | Ticker | Δ Since Trade |
|---|---|---|---|---|---|---|---|---|
| Senate | Nov. 2, 2018 | David Perdue | Joint | Pfizer Inc. | SALE (PARTIAL) | $1,001 - $15,000 | PFE | ▼ -39.43% |
| Senate | Nov. 1, 2018 | David Perdue | Joint | Pfizer Inc. | SALE (PARTIAL) | $1,001 - $15,000 | PFE | ▼ -40.46% |
| Senate | Feb. 9, 2017 | David Perdue | Joint | Pfizer Inc. | PURCHASE | $1,001 - $15,000 | PFE | ▼ -19.68% |
| Senate | Jan. 13, 2016 | David Perdue | Joint | Pfizer Inc. | SALE (PARTIAL) | $1,001 - $15,000 | PFE | ▼ -14.38% |
| Senate | Feb. 17, 2017 | David Perdue | Joint | Pfizer Inc. | PURCHASE | $1,001 - $15,000 | PFE | ▼ -22.65% |
| Senate | Feb. 22, 2017 | David Perdue | Joint | Pfizer Inc. | PURCHASE | $15,001 - $50,000 | PFE | ▼ -22.58% |
| Senate | Feb. 7, 2017 | David Perdue | Joint | Pfizer Inc. | PURCHASE | $1,001 - $15,000 | PFE | ▼ -18.94% |
| Senate | Feb. 13, 2025 | John Boozman | Joint | Pfizer Inc | SALE (FULL) | $1,001 - $15,000 | PFE | ▼ -3.86% |
| Senate | Jul. 25, 2023 | Tommy Tuberville | Joint | Pfizer, Inc. Common Stock | PURCHASE | $1,001 - $15,000 | PFE | ▼ -33.49% |
| Senate | Jun. 12, 2023 | Tommy Tuberville | Joint | Pfizer, Inc. Common Stock | PURCHASE | $1,001 - $15,000 | PFE | ▼ -38.22% |
| Senate | Jan. 12, 2022 | Tommy Tuberville | Joint | Pfizer, Inc. Common Stock | PURCHASE | $1,001 - $15,000 | PFE | ▼ -56.49% |
| House | Feb. 12, 2025 | Julie Johnson | Joint | Pfizer Inc | SALE | $1,001 - $15,000 | PFE | ▼ -3.22% |
| Senate | Feb. 26, 2020 | David Perdue | Joint | Pfizer Inc. | PURCHASE | $1,001 - $15,000 | PFE | ▼ -25.10% |
| Senate | Feb. 27, 2020 | David Perdue | Joint | Pfizer Inc. | PURCHASE | $1,001 - $15,000 | PFE | ▼ -23.76% |
| Senate | Feb. 28, 2020 | David Perdue | Joint | Pfizer Inc. | PURCHASE | $1,001 - $15,000 | PFE | ▼ -22.19% |
| Senate | Apr. 14, 2020 | David Perdue | Joint | Pfizer Inc. | SALE (FULL) | $100,001 - $250,000 | PFE | ▼ -28.63% |
| Senate | Apr. 3, 2020 | David Perdue | Joint | Pfizer Inc. | SALE (PARTIAL) | $1,001 - $15,000 | PFE | ▼ -22.70% |
| Senate | Apr. 7, 2020 | Kelly Loeffler | Joint | Pfizer Inc. | SALE (FULL) | $100,001 - $250,000 | PFE | ▼ -22.63% |
| Senate | Feb. 26, 2020 | David Perdue | Joint | Pfizer Inc. | PURCHASE | $1,001 - $15,000 | PFE | ▼ -25.10% |
| Senate | Feb. 27, 2020 | David Perdue | Joint | Pfizer Inc. | PURCHASE | $15,001 - $50,000 | PFE | ▼ -23.76% |
| Senate | Feb. 26, 2020 | David Perdue | Joint | Pfizer Inc. | PURCHASE | $15,001 - $50,000 | PFE | ▼ -25.10% |
| Senate | Feb. 27, 2020 | David Perdue | Joint | Pfizer Inc. | PURCHASE | $1,001 - $15,000 | PFE | ▼ -23.76% |
| Senate | Feb. 28, 2020 | David Perdue | Joint | Pfizer Inc. | PURCHASE | $15,001 - $50,000 | PFE | ▼ -22.19% |
| Senate | Nov. 19, 2018 | David Perdue | Joint | Pfizer Inc. | SALE (PARTIAL) | $1,001 - $15,000 | PFE | ▼ -41.14% |
| Senate | May. 3, 2024 | Tommy Tuberville | Joint | Pfizer, Inc. Common Stock | SALE (FULL) | $15,001 - $50,000 | PFE | ▼ -11.36% |
| Senate | Nov. 5, 2018 | David Perdue | Joint | Pfizer Inc. | SALE (PARTIAL) | $15,001 - $50,000 | PFE | ▼ -40.24% |
| Senate | Nov. 12, 2018 | David Perdue | Joint | Pfizer Inc. | SALE (PARTIAL) | $1,001 - $15,000 | PFE | ▼ -41.04% |
| Senate | Oct. 31, 2018 | David Perdue | Joint | Pfizer Inc. | SALE (PARTIAL) | $15,001 - $50,000 | PFE | ▼ -39.61% |
| Senate | Oct. 2, 2018 | David Perdue | Joint | Pfizer Inc. | SALE (PARTIAL) | $1,001 - $15,000 | PFE | ▼ -41.20% |
| Senate | Oct. 12, 2018 | David Perdue | Joint | Pfizer Inc. | SALE (PARTIAL) | $1,001 - $15,000 | PFE | ▼ -40.60% |
Last updated: Nov 2, 14:16